The Effects of Parathyroid Hormone and Alendronate Alone or in Combination in Postmenopausal Osteoporosis-Reference-Cited by-同舟云学术

The Effects of Parathyroid Hormone and Alendronate Alone or in Combination in Postmenopausal Osteoporosis

Published:2003-09-25 Issue:13 Volume:349 Page:1207-1215
ISSN:0028-4793
Container-title:New England Journal of Medicine
language:en
Short-container-title:N Engl J Med

Author:

Black Dennis M.,Greenspan Susan L.,Ensrud Kristine E.,Palermo Lisa,McGowan Joan A.,Lang Thomas F.,Garnero Patrick,Bouxsein Mary L.,Bilezikian John P.,Rosen Clifford J.

Publisher

Massachusetts Medical Society

Subject

General Medicine

Link

http://www.nejm.org/doi/pdf/10.1056/NEJMoa031975

Cited by 1037 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effects of daily teriparatide, weekly high-dose teriparatide, or bisphosphonate on cortical and trabecular bone of vertebra and proximal femur in postmenopausal women with fragility fracture: Sub-analysis by quantitative computed tomography from the TERABIT study;Bone;2024-10

2. Hydroxychloroquine and a low antiresorptive activity bisphosphonate conjugate prevent and reverse ovariectomy-induced bone loss in mice through dual antiresorptive and anabolic effects;Bone Research;2024-09-05

3. Romosozumab versus parathyroid hormone receptor agonists: which osteoanabolic to choose and when?;European Journal of Endocrinology;2024-06-28

4. Jiangu formula: A novel osteoclast-osteoblast coupling agent for effective osteoporosis treatment;Phytomedicine;2024-06

5. Diagnosing Osteoporosis at Menopause: Options Available Apart from DEXA;Journal of South Asian Federation of Obstetrics and Gynaecology;2024-04-29